Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

No Impact of Donor's Age-Related Clonal Hematopoiesis (ARCH) Observed on Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation: Result from Bar-Coded Error Corrected Sequencing in 33 Gene Mutations on 372 Pairs of Donor and Recipient

Kyoung Ha Kim, MD PhD, Taehyung Kim, MSc, Jae-Sook Ahn, MD PhD, Zeyad Al-Shaibani, Arjun Law, MD, Wilson Lam, MD, Fotios V. Michelis, MD PhD, Auro Viswabandya, MDDM, Jeffrey H. Lipton, MD PhD, Rajat Kumar, MD, Jonas Mattsson, MD, Zhaolei Zhang, PhD, Tamir Biezuner, PhD, Liran I. Shlush, MD, Dennis Dong Hwan Kim, MD PhD

Blood (2019) 134 (Supplement_1): 4514.

https://doi.org/10.1182/blood-2019-129497

Published: 2019

Journal Articles

Clinical Impact of Enrollment of Clinical Trial in Multiple Myeloma; Single Center Experience

Seo-Yeon Ahn, MD, Sung-Hoon Jung, MD, Ga-Young Song, Deok-Hwan Yang, MD PhD, Jae-Sook Ahn, MD PhD, Hyeoung-Joon Kim, MD PhD, Je-Jung Lee, MD PhD

Blood (2019) 134 (Supplement_1): 5525.

https://doi.org/10.1182/blood-2019-127889

Published: 2019

Journal Articles

Prognostic Impact of a Composite Genetic Profile Defined By Cytogenetics and Next Generation Sequencing at Diagnosis on Treatment Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

Blood (2019) 134 (Supplement_1): 3317.

https://doi.org/10.1182/blood-2019-125780

Published: 2019

Journal Articles

18 f-FDG PET/CT and the Revised International Staging System Are More Discriminating of Survival Outcomes in Newly Diagnosed Multiple Myeloma

Sung-Hoon Jung, MD, Seong Young Kwon, Jung-Joon Min, Hee Seung Bom, Seo-Yeon Ahn, MD, Seung-Yeon Jung, Seung-Shin Lee, MD, Moo-Rim Park, MD, Deok-Hwan Yang, MD, Jae-Sook Ahn, MD PhD, Hyeoung-Joon Kim, MD PhD, Je-Jung Lee, MD PhD

Blood (2018) 132 (Supplement 1): 4483.

https://doi.org/10.1182/blood-2018-99-112354

Published: 2018

Journal Articles

Identification of High Risk Group for Leukemic Transformation in Higher Risk MDS Patients Using Targeted RNA-Sequencing: Hematopoietic Stem Cell Signature As a High Risk Profile for Leukemic Transformation

Joon Ho Moon, MD, Taehyung Kim, MSc, Jae-Sook Ahn, MD PhD, Seo-Yeon Ahn, MD, Sung-Hoon Jung, MD, Deok-Hwan Yang, MD, Je-Jung Lee, MD PhD, Seunghyun Choi, PhD, Yoojin Lee, MD PhD, Sang Kyun Sohn, MD PhD, Hyeoung-Joon Kim, MD PhD, Zhaolei Zhang, PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2018) 132 (Supplement 1): 4361.

https://doi.org/10.1182/blood-2018-99-116241

Published: 2018

Journal Articles

Prognostic Significance of FDG-PET/CT on Determining Upfront Autologous Stem Cell Transplantation for the Treatment of Peripheral T Cell Lymphomas

Seo-Yeon Ahn, MD, Seung-Yeon Jung, Sung-Hoon Jung, MD, Jae-Sook Ahn, MD PhD, Je-Jung Lee, MD PhD, Hyeoung-Joon Kim, MD PhD, Sae-Ryung Kang, MD, Yeon-Hee Han, MD, Jae-Yong Kwak, MD PhD, Ho-Young Yhim, MD PhD, Deok-Hwan Yang, MD PhD

Blood (2018) 132 (Supplement 1): 1632.

https://doi.org/10.1182/blood-2018-99-118168

Published: 2018

Journal Articles

RNA Sequencing-Based Measurement of Fusion-Transcript for Minimal Residual Disease (MRD) Monitoring in Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)

Taehyung Kim, MSc, Joon Ho Moon, MD, Jae-Sook Ahn, MD PhD, Marc S. Tyndel, B. Eng, Seung-Shin Lee, MD, Seo-Yeon Ahn, MD, Sung-Hoon Jung, MD, Deok-Hwan Yang, MD PhD, Je-Jung Lee, MD PhD, Seunghyun Choi, PhD, Ja-yeon Lee, MSc, Yoojin Lee, MDPhD, Sang Kyun Sohn, MD PhD, Zhaolei Zhang, PhD, Hyeoung-Joon Kim, MD PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2018) 132 (Supplement 1): 2669.

https://doi.org/10.1182/blood-2018-99-112037

Published: 2018

Journal Articles

Residual Allelic Burden Measured By Next-Generation Sequencing (NGS) at Remission Provides Limited Prognostic Value to Predict Relapse and Long-Term Outcome in Core Binding Factor Acute Myeloid Leukemia (CBF-AML)

Taehyung Kim, MSc, Joon Ho Moon, MD, Jae-Sook Ahn, MD PhD, Marc S. Tyndel, B. Eng, Seung-Shin Lee, MD, Seo-Yeon Ahn, MD, Sung-Hoon Jung, MD, Deok-Hwan Yang, MD, Je-Jung Lee, MD PhD, Seunghyun Choi, PhD, Ja-yeon Lee, MSc, Yoojin Lee, MDPhD, Sang Kyun Sohn, MDPhD, Hyeoung-Joon Kim, MD PhD, Zhaolei Zhang, PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2018) 132 (Supplement 1): 1391.

https://doi.org/10.1182/blood-2018-99-112906

Published: 2018

Journal Articles

The Clonal Origins of Leukemic Progression of Myelodysplasia

Taehyung Kim, MSc, Marc Tyndel, Hyeoung Joon Kim, MD, Jae-Sook Ahn, MD PhD, Seung Hyun Choi, PhD, Hee Jeong Park, Yeo-Kyeoung Kim, MD PhD, Deok-Hwan Yang, Je-Jung Lee, Sung-Hoon Jung, Soo Young Kim, Yoo-Hong Min, June-Won Cheong, MD, Sang Kyun Sohn, MD, PhD, Joon Ho Moon, MD, PhD, Murim Choi, Moses Lee, Zhaolei Zhang, PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2016) 128 (22): 4307.

https://doi.org/10.1182/blood.V128.22.4307.4307

Published: 2016

Journal Articles

Killer Cell Immunoglobulin-like Receptor Ligand Matching Determines the Post-Transplant High Risk Groups Among Patients with Permissive HLA Mismatch in Unrelated Donor Hematopoietic Cell Transplantation

Yoo Jin Lee, MD, Joon Ho Moon, MD, PhD, In Hee Lee, MD, Jae-Ho Yoon, Byung-Sik Cho, Jae-Sook Ahn, MD PhD, Hyeoung Joon Kim, MD PhD, Silvia Park, Jun Ho Jang, MD PhD, Chul Won Jung, MD PhD, Hyunsung Park, MD, June-Won Cheong, MD, Je-Hwan Lee, MD PhD, Sang Kyun Sohn, MD, PhD, Hee-Je Kim

Blood (2016) 128 (22): 4566.

https://doi.org/10.1182/blood.V128.22.4566.4566

Published: 2016

Journal Articles

Efficacy and Safety Of Eltrombopag In Korean Adult Patients With Refractory Chronic Immune Thrombocytopenia

Yeo-Kyeoung Kim, MD, PhD, Sung-Hoon Chung, MD, PhD, Jae-Sook Ahn, MD, PhD, Deok-Hwan Yang, MD, PhD, Il-Kwon Lee, PhD, Nan-Young Kim, PhD, Li Yu, PhD, Je-Jung Lee, MD, PhD, Hyeoung-Joon Kim, MD, PhD

Blood (2013) 122 (21): 4758.

https://doi.org/10.1182/blood.V122.21.4758.4758

Published: 2013

Journal Articles

The Prognostic Significance Of Interim PET/CT Using Visual, SUV-Based and MTV-Based Assessment In Treatment Of Peripheral T Cell Lymphoma

Deok-Hwan Yang, MD, PhD, Jung-Joon Min, Jae-Sook Ahn, MD, PhD, Yeo-Kyeoung Kim, MD.PhD., Hee-Seung Bom, Hyeoung-Joon Kim, MD, PhD, Yee Soo Chae, M.D., Sang Kyun Sohn, Sang Woo Lee, Young-Rok Do, PhD, Je-Jung Lee, MD, PhD

Blood (2013) 122 (21): 4261.

https://doi.org/10.1182/blood.V122.21.4261.4261

Published: 2013

Journal Articles

Effect Of Advanced Lytic Bone Lesions On Peripheral Stem Cell Mobilization In Patients With Multiple Myeloma

Sung-Hoon Jung, MD, Jae-Sook Ahn, MD, PhD, Deok-Hwan Yang, MD, PhD, Yeo-Kyeoung Kim, MD, PhD, Hyeoung-Joon Kim, MD, PhD, Je-Jung Lee, MD, PhD

Blood (2013) 122 (21): 3276.

https://doi.org/10.1182/blood.V122.21.3276.3276

Published: 2013

Journal Articles

Role Of Hypomethylating Agents For Patients With Lower-Risk Myelodysplastic Syndrome Defined By IPSS and IPSS-R

Joon Ho Moon, M.D., Ph.D, Sang Kyun Sohn, MD, PhD, Jae Sook Ahn, MD, Yeo-Kyeoung Kim, MD, PhD, Hyeoung Joon Kim, MD, PhD, Moo-Kon Song, MD, Ho-Jin Shin, Joo-Seop Chung, MD, PhD, Ik Chan Song, MD, Deog-Yeon Jo, MD, PhD, Sung Nam Lim, MD, Ho Sup Lee, Yang Soo Kim, MD, PhD, Sung Hwa Bae

Blood (2013) 122 (21): 2782.

https://doi.org/10.1182/blood.V122.21.2782.2782

Published: 2013

Journal Articles

Clinical Significance Of SF3B1, U2AF1 and SRSF2 Spliceosomal Gene Mutations For The Treatment Of Hypomethylating Agents In Myelodysplastic Syndrome

Jae-Sook Ahn, MD, PhD, Hye-Ran Kim, PhD, Hyeoung-Joon Kim, MD, PhD, Yeo-Kyeoung Kim, MD, PhD, Sung-Hoon Jung, MD, Deok-Hwan Yang, MD, PhD, Je-Jung Lee, MD, PhD, Nguyen Thi Dai Trang, Hyun-Woo Choi, MD, Min-Gu Kang, MD, Hwan-Young Kim, Jong-Hee Shin, MD, PhD, Soon-Pal Suh, MD, PhD, Dong-Wook Ryang, MD, PhD, Myung-Geun Shin, MD, PhD

Blood (2013) 122 (21): 2802.

https://doi.org/10.1182/blood.V122.21.2802.2802

Published: 2013

Journal Articles

Whole Exome Sequencing Analysis in AML with Normal Karyotype Not Harboring FLT3/ITD Mutation Reveals Novel Genetic Alterations.

Blood (2012) 120 (21): 2593.

https://doi.org/10.1182/blood.V120.21.2593.2593

Published: 2012

Journal Articles

Sustained Long-Term MMR to a Reduced Dose of Imatinib in Chronic-Phase CML: A Pilot Study of SLC22A1 Gene Polymorphisms

Se Ryeon Lee, MD, PhD, Seok Young Lee, MD, Dae Sik Kim, MD, Yong Park, MD, Hwa Jung Sung, Chul Won Choi, MD, Jae Sook Ahn, MD, Deok-Hwan Yang, MD, PhD, Byung Soo Kim, MD, PhD

Blood (2012) 120 (21): 4449.

https://doi.org/10.1182/blood.V120.21.4449.4449

Published: 2012

Journal Articles

Relapse Pattern After Bortezomib Based Salvage Therapy in Patients with Multiple Myeloma

Jae-Sook Ahn, MD, PhD, Deok-Hwan Yang, MD, PhD, Sung-Hoon Jung, MD, Se Ryeon Lee, MD, PhD, Yeo-Kyeoung Kim, MD, PhD, Hyeoung-Joon Kim, MD, PhD, Je-Jung Lee, MD, PhD

Blood (2012) 120 (21): 1869.

https://doi.org/10.1182/blood.V120.21.1869.1869

Published: 2012

Journal Articles

High Dose Etoposide Plus G-CSF As an Effective Mobilization Regimen in Patients with NHL Previously Treated with R-CHOP or CHOP Chemotherapy. Retrospective Multicenter Study

Shin Young Hyun, Yu Ri Kim, yun Deok Kim, Do Yoo Whang, Soo Jeong Kim, June-Won Cheong, Hong Ghi Lee, Deok-Hwan Yang, Jae Sook Ahn, MD, Won-Sik Lee, Ryu Hon Mo, Young-Rok Do, Ho Sup Lee, MD, Jae Hoon Lee, Sung Yong Oh, Cheolwon Suh, MD, Ho-Young Yhim, Jin Seok Kim

Blood (2012) 120 (21): 1917.

https://doi.org/10.1182/blood.V120.21.1917.1917

Published: 2012

Journal Articles

Lymphocytopenia Is Associated with an Increased Risk of Severe Infections in Patients with Multiple Myeloma Treated with Bortezomib-Based Regimens

Sung-Hoon Jung, MD, Jae-Sook Ahn, MD, PhD, Seung-Ji Kang, MD, Deok-Hwan Yang, MD, PhD, Yeo-Kyeoung Kim, MD, PhD, Hyeoung-Joon Kim, MD, PhD, Je-Jung Lee, MD, PhD

Blood (2012) 120 (21): 5042.

https://doi.org/10.1182/blood.V120.21.5042.5042

Published: 2012

NARROW

No Impact of Donor's Age-Related Clonal Hematopoiesis (ARCH) Observed on Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation: Result from Bar-Coded Error Corrected Sequencing in 33 Gene Mutations on 372 Pairs of Donor and Recipient

Clinical Impact of Enrollment of Clinical Trial in Multiple Myeloma; Single Center Experience

Prognostic Impact of a Composite Genetic Profile Defined By Cytogenetics and Next Generation Sequencing at Diagnosis on Treatment Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

18 f-FDG PET/CT and the Revised International Staging System Are More Discriminating of Survival Outcomes in Newly Diagnosed Multiple Myeloma

Identification of High Risk Group for Leukemic Transformation in Higher Risk MDS Patients Using Targeted RNA-Sequencing: Hematopoietic Stem Cell Signature As a High Risk Profile for Leukemic Transformation

Prognostic Significance of FDG-PET/CT on Determining Upfront Autologous Stem Cell Transplantation for the Treatment of Peripheral T Cell Lymphomas

RNA Sequencing-Based Measurement of Fusion-Transcript for Minimal Residual Disease (MRD) Monitoring in Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)

Residual Allelic Burden Measured By Next-Generation Sequencing (NGS) at Remission Provides Limited Prognostic Value to Predict Relapse and Long-Term Outcome in Core Binding Factor Acute Myeloid Leukemia (CBF-AML)

The Clonal Origins of Leukemic Progression of Myelodysplasia

Killer Cell Immunoglobulin-like Receptor Ligand Matching Determines the Post-Transplant High Risk Groups Among Patients with Permissive HLA Mismatch in Unrelated Donor Hematopoietic Cell Transplantation

Efficacy and Safety Of Eltrombopag In Korean Adult Patients With Refractory Chronic Immune Thrombocytopenia

The Prognostic Significance Of Interim PET/CT Using Visual, SUV-Based and MTV-Based Assessment In Treatment Of Peripheral T Cell Lymphoma

Effect Of Advanced Lytic Bone Lesions On Peripheral Stem Cell Mobilization In Patients With Multiple Myeloma

Role Of Hypomethylating Agents For Patients With Lower-Risk Myelodysplastic Syndrome Defined By IPSS and IPSS-R

Clinical Significance Of SF3B1, U2AF1 and SRSF2 Spliceosomal Gene Mutations For The Treatment Of Hypomethylating Agents In Myelodysplastic Syndrome

Whole Exome Sequencing Analysis in AML with Normal Karyotype Not Harboring FLT3/ITD Mutation Reveals Novel Genetic Alterations.

Sustained Long-Term MMR to a Reduced Dose of Imatinib in Chronic-Phase CML: A Pilot Study of SLC22A1 Gene Polymorphisms

Relapse Pattern After Bortezomib Based Salvage Therapy in Patients with Multiple Myeloma

High Dose Etoposide Plus G-CSF As an Effective Mobilization Regimen in Patients with NHL Previously Treated with R-CHOP or CHOP Chemotherapy. Retrospective Multicenter Study

Lymphocytopenia Is Associated with an Increased Risk of Severe Infections in Patients with Multiple Myeloma Treated with Bortezomib-Based Regimens

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only